Effect of SDF-1 α on endogenous mobilized and transplanted stem cells in regeneration after Myocardial Infarction

Current Pharmaceutical Design

Volumn 20, Issue 12, 2014, Pages 1964-1970

  Schu, Alexander ^a   Konschalla, Simone ^a   Kroh, Andreas ^a   Schober, Andreas ^a   Marx, Nikolaus ^a   Sönmez, Tolga Taha ^a   Zenke, Martin ^a   Sasse, Alexander ^b   Liehn, Elisa A ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cell recruitment; Cell transplantation; Chemokines; Myocardial regeneration; Stromal derived factor 1

Indexed keywords

CD31 ANTIGEN; CYTOKINE ANTIBODY; GREEN FLUORESCENT PROTEIN; STROMAL CELL DERIVED FACTOR 1ALPHA; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW; BONE MARROW CELL; CELL LABELING; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; ENDOTHELIAL PROGENITOR CELL; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATION; REPERFUSION INJURY; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; METABOLISM; MYOCARDIAL INFARCTION; PHYSIOLOGY; PROCEDURES;

ANIMALS; CELLS, CULTURED; CHEMOKINE CXCL12; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; REGENERATION; STEM CELL TRANSPLANTATION;

EID: 84898611442     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990443     Document Type: Article

References (40)

1. Czarnowska E, Gajerska-Dzieciatkowska M, Kusmierski K, et al. Expression of SDF-1-CXCR4 axis and an anti-remodelling effectiveness of foetal-liver stem cell transplantation in the infarcted rat heart. J Physiol Pharmacol 2007; 58(4): 729-744.
2. Fuchs S, Baffour R, Zhou YF, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am College Cardiol 2001; 37(6): 1726-1732.
3. Halkos ME, Zhao ZQ, Kerendi F, et al. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Basic research in cardiology 2008; 103(6): 525-536.
4. Merx MW, Zernecke A, Liehn EA, et al. Transplantation of human umbilical vein endothelial cells improves left ventricular function in a rat model of myocardial infarction. Basic Res Cardiol 2005; 100(3): 208-216.
5. Schuh A, Liehn EA, Sasse A, et al. Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model. Basic research in cardiology 2008; 103(1): 69-77.
6. Schuh A, Liehn EA, Sasse A, et al. Improved left ventricular func-tion after transplantation of microspheres and fibroblasts in a rat model of myocardial infarction. Basic Res Cardiol 2009; 104(4): 403-411.
7. Skobel E, Schuh A, Schwarz ER, et al. Transplantation of fetal cardiomyocytes into infarcted rat hearts results in long-term functional improvement. Tissue Engineering 2004; 10(5-6): 849-864.
8. Tomita S, Li RK, Weisel RD, et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999; 100(19 Suppl): II247-II256.
9. Chavakis E, Koyanagi M, Dimmeler S. Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedside and back. Circulation.; 121(2): 325-335.
10. Simons M, Bonow RO, Chronos NA, et al. Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary. Circulation 2000; 102(11): E73-E86.
11. Liehn EA, Postea O, Curaj A, Marx N. Repair after myocardial infarction, between fantasy and reality: the role of chemokines. Journal of the American College of Cardiology.; 58(23): 2357-2362.
12. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovascular Res 2002; 53(1): 31-47.
13. Liehn EA, Merx MW, Postea O, et al. Ccr1 deficiency reduces inflammatory remodelling and preserves left ventricular function after myocardial infarction. J Cellular Mol Med 2008; 12(2): 496-506.
14. Liehn EA, Tuchscheerer N, Kanzler I, et al. Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction. J Am College Cardiol; 58(23): 2415-2423.
15. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004; 110(21): 3300-3305.
16. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kie-drowski M, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362(9385): 697-703.
17. De Falco E, Porcelli D, Torella AR, et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004; 104(12): 3472-3482.
18. Yu J, Li M, Qu Z, Yan D, Li D, Ruan Q. SDF-1/CXCR4-mediated migration of transplanted bone marrow stromal cells toward areas of heart myocardial infarction through activation of PI3K/Akt. J Cardiovascular Pharmacol; 55(5): 496-505.
19. Agarwal U, Ghalayini W, Dong F, et al. Role of cardiac myocyte CXCR4 expression in development and left ventricular remodeling after acute myocardial infarction. Circulation Res; 107(5): 667-676.
20. Kortesidis A, Zannettino A, Isenmann S, Shi S, Lapidot T, Gronthos S. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 2005; 105(10): 3793-3801.
21. Reddy K, Zhou Z, Jia SF, et al. Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor. International journal of cancer 2008; 123(4): 831-837.
22. Schober A, Karshovska E, Zernecke A, Weber C. SDF-1αlpha-mediated tissue repair by stem cells: a promising tool in cardiovascular medicine? Trends Cardiovasc Med 2006; 16(4): 103-108.
23. Segers VF, Tokunou T, Higgins LJ, MacGillivray C, Gannon J, Lee RT. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 2007; 116(15): 1683-1692.
24. Schuh A, Kroh A, Konschalla S, et al. Myocardial regeneration by transplantation of modified endothelial progenitor cells expressing SDF-1 in a rat model. J Cellular Mol Med Jan 30.
25. Zhang D, Fan GC, Zhou X, et al. Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarc-ted myocardium. J Mol Cellular Cardiol 2008; 44(2): 281-292.
26. Zhang M, Mal N, Kiedrowski M, et al. SDF-1 expression by mes-enchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. Faseb J 2007; 21(12): 3197-3207.
27. Liles WC, Broxmeyer HE, Rodger E, et al. Mobilization of hema-topoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 2003; 102(8): 2728-2730.
28. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS letters 1997; 407(3): 313-319.
29. Liehn EA, Piccinini AM, Koenen RR, et al. A new monocyte che-motactic protein-1/chemokine CC motif ligand-2 competitor limiting neointima formation and myocardial ischemia/reperfusion injury in mice. J Am College Cardiol; 56(22): 1847-1857.
30. Schuh A, Breuer S, Al Dashti R, et al. Administration of vascular endothelial growth factor adjunctive to fetal cardiomyocyte transplantation and improvement of cardiac function in the rat model. J Cardiovascular Pharmacol Therapeut 2005; 10(1): 55-66.
31. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392(6676): 565-568.
32. Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 2000; 95(10): 3032-3043.
33. Brunner S, Winogradow J, Huber BC, et al. Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis. Faseb J 2009; 23(2): 351-361.
34. Klopsch C, Furlani D, Gabel R, et al. Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model. J Cellular Mol Med 2009; 13(4): 664-679.
35. Misao Y, Arai M, Ohno T, et al. Modification of post-myocardial infarction granulocyte-colony stimulating factor therapy with myelo-suppressives. Circ J 2007; 71(4): 580-590.
36. Zhang D, Huang W, Dai B, et al. Genetically manipulated progenitor cell sheet with diprotin A improves myocardial function and repair of infarcted hearts. Am J Physiol; 299(5): H1339-H1347.
37. Chen T, Bai H, Shao Y, et al. Stromal cell-derived factor-1/CXCR4 signaling modifies the capillary-like organization of human embryonic stem cell-derived endothelium in vitro. Stem cells (Dayton, Ohio) 2007; 25(2): 392-401.
38. Elmadbouh I, Haider H, Jiang S, Idris NM, Lu G, Ashraf M. Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cellular Cardiol 2007; 42(4): 792-803.
39. Tang J, Wang J, Song H, et al. Adenovirus-mediated stromal cell-derived factor-1 alpha gene transfer improves cardiac structure and function after experimental myocardial infarction through angio-genic and antifibrotic actions. Mol Biol Reports; 37(4): 1957-1969.
40. Thieme S, Ryser M, Gentsch M, et al. Stromal cell-derived factor-1alpha-directed chemoattraction of transiently CXCR4-overexpressing bone marrow stromal cells into functionalized three-dimensional biomimetic scaffolds. Tissue Eng Part C Methods 2009; 15(4): 687-696.